---
company: MICROVISION, INC.
ticker: MVIS
form: 8-K
filed: 2026-08-06
accession: 0001493152-26-036350
source: https://www.sec.gov/Archives/edgar/data/65770/000149315226036350/
---

# Microvision (MVIS) earnings release, August 6, 2026

Microvision, Inc. (MVIS) · Form 8-K, Item 2.02 · Filed 2026-08-06 · [SEC filing](https://www.sec.gov/Archives/edgar/data/65770/000149315226036350/)

Exhibit

99.1

MicroVision

Reports Second Quarter 2026 Results and Highlights Commercial Momentum Across Multiple Markets

Advancing

Lidar 2.0 strategy with expanding customer engagements, new product launches, strengthened leadership team, improved cash burn guidance, and growing commercial pipeline

REDMOND,

Wash. – August 6, 2026 – MicroVision, Inc. (NASDAQ: MVIS), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, today announced its second quarter 2026 results and provided a business update highlighting continued execution of its Lidar 2.0 strategy.

Key

Operational Highlights

“Our second quarter demonstrates that MicroVision has evolved into a commercially focused perception company with the products, technology, leadership and operational discipline needed to compete across multiple high-growth markets,” said Glen DeVos, Chief Executive

Officer of MicroVision. “Our Lidar 2.0 strategy is translating into meaningful commercial momentum and a path to near-term and future revenue.”

“Our strategy is simple: deliver the right perception solutions at the right cost across multiple industries. We’re leveraging a common technology platform to address opportunities spanning industrial automation, security and defense, autonomous aerial systems, robotics and automotive. Every new customer, product and market reinforces the scalability of our business model and the trajectory of our revenue growth.”

Key

Financial Highlights for Q2 2026

As of June 30, 2026, the Company has access to $68.4 million of capital, subject to certain conditions, including $41.2 million under its existing ATM, or at-the-market, facility and expects future financing activities to support continued execution of its strategic plan.

Conference

Call

MicroVision will host a conference call today at

4:30 p.m. Eastern Time to discuss second quarter 2026 financial results and provide a business update.

The live webcast can be accessed on the Investor Relations section of the Company’s website at www.microvision.com. A replay of the webcast will be available following the conclusion of the call.

About

MicroVision

MicroVision is defining the next generation of lidar-based perception solutions for automotive, industrial, and security & defense markets. As the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions.

For more information, visit the Company’s website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision

/.

MicroVision,

MAVIN, MOSAIK, MOVIA, IRIS, and SENTINEL are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Non-GAAP

Information

To supplement MicroVision’s condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures “adjusted EBITDA” and “adjusted Gross Profit.” Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; non-cash gains and losses; share-based compensation; restructuring costs; acquisition-related costs; and impairment charges. Adjusted

Gross Profit is calculated as GAAP gross profit before share-based compensation expense, inventory write downs, and the amortization of acquired intangibles included in cost of revenue.

MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision’s past financial reports, and facilitates comparisons with other companies in the Company’s industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company’s operating results and facilitates comparisons of the Company’s core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision’s operating performance and the valuation of the Company.

Adjusted

EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision’s business as determined in accordance with GAAP.

The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.

The

Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company... (truncated)GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted

EBITDA.

Similarly for adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.

Forward-Looking

Statements

Certain statements contained in this release, including market position, expectations, and likelihood of success; opportunities for customer engagement and revenue; expense reduction; benefits of acquisitions and integration synergies; market position; product portfolio; product and manufacturing capabilities; transaction benefits; access to capital and capital-raising opportunities; and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company’s SEC reports, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor

Relations Contact

Jeff

Christensen

Darrow

Associates Investor Relations

MVIS@darrowir.com

Media

Contact

Heidi

Davidson - For MicroVision heidi@galvanizeworldwide.com

(914)

441-6862

MicroVision,

Inc.

Consolidated

Balance Sheets

(In thousands)

MicroVision,

Inc.

Consolidated

Statement of Operations

(In thousands, except per share data)

MicroVision,

Inc.

Consolidated

Statements of Cash Flows

(In thousands)

The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of June 30, 2026 and

2025:

MicroVision,

Inc.

Reconciliation of GAAP to Non-GAAP Measures

(In thousands)

## Financial statements

### Income Statement (Three months ended June 30, — (In thousands, except per share data))

| | Three months ended June 30, – 2026 | Three months ended June 30, – 2025 | Six months ended June 30, – 2026 | Six months ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Revenue | 1,473 | 155 | 2,408 | 744 |
| Cost of revenue | 831 | 716 | 1,403 | 1,266 |
| Gross profit (loss) | 642 | -561 | 1,005 | -522 |
| Research and development expense | 15,702 | 7,658 | 30,147 | 15,061 |
| Sales, marketing, general and administrative expense | 9,211 | 6,437 | 18,722 | 13,113 |
| Impairment loss on operating lease right-of-use assets |  |  | 9 |  |
| Gain on disposal of fixed assets | -60 |  | -168 |  |
| Total operating expenses | 24,853 | 14,095 | 48,710 | 28,174 |
| Loss from operations | -24,211 | -14,656 | -47,705 | -28,696 |
| Interest expense | -5,480 | -2,170 | -8,233 | -15,073 |
| Unrealized gain (loss) on derivative liability | -8,035 | 1,952 | -4,655 | 2,794 |
| Unrealized gain on warrant liability | 891 | 803 | 1,495 | 2,564 |
| Realized loss on debt extinguishment |  |  | -3,083 | -4,654 |
| Bargain purchase gain |  |  | 147 |  |
| Other income (expense) | 73 | -65 | 160 | 223 |
| Net loss before taxes | -36,762 | -14,136 | -61,874 | -42,842 |
| Income tax expense | -181 | -93 | -363 | -166 |
| Net loss | -36,943 | -14,229 | -62,237 | -43,008 |
| Net loss per share - basic and diluted | -1.66 | -0.84 | -2.9 | -2.63 |
| Weighted-average shares outstanding - basic and diluted | 22,296 | 16,977 | 21,441 | 16,356 |

### Income Statement (Three months ended June 30, — (In thousands) (in thousands))

| | Three months ended June 30, – 2026 | Three months ended June 30, – 2025 | Six months ended June 30, – 2026 | Six months ended June 30, – 2025 |
|---|---:|---:|---:|---:|
| Reconciliation of Non-GAAP Gross Profit: | Gross profit (loss) | 642 | -561 | 1,005 | -522 |
| Reconciliation of Non-GAAP Gross Profit: | Inventory related write-downs | 25 |  | 52 |  |
| Reconciliation of Non-GAAP Gross Profit: | Amortization of acquired intangibles |  | 217 |  | 434 |
| Reconciliation of Non-GAAP Gross Profit: | Adjusted Gross Profit | 667 | -344 | 1,057 | -88 |
| Reconciliation of Non-GAAP Loss: | GAAP Net loss | -36,943 | -14,229 | -62,237 | -43,008 |
| Reconciliation of Non-GAAP Loss: | Interest expense, net | 5,407 | 2,235 | 8,073 | 14,850 |
| Reconciliation of Non-GAAP Loss: | Provision for income taxes | 181 | 93 | 363 | 166 |
| Reconciliation of Non-GAAP Loss: | Depreciation and amortization | 2,976 | 1,544 | 5,344 | 2,952 |
| Reconciliation of Non-GAAP Loss: | Unrealized (gain) loss on derivative liability | 8,035 | -1,952 | 4,655 | -2,794 |
| Reconciliation of Non-GAAP Loss: | Unrealized gain on warrant liability | -891 | -803 | -1,495 | -2,564 |
| Reconciliation of Non-GAAP Loss: | Loss on debt extinguishment |  |  | 3,083 | 4,654 |
| Reconciliation of Non-GAAP Loss: | Gain on disposal of fixed assets | -60 |  | -168 |  |
| Reconciliation of Non-GAAP Loss: | Impairment of operating lease right-of-use assets |  |  | 9 |  |
| Reconciliation of Non-GAAP Loss: | Share-based compensation expense | 1,304 | 1,930 | 2,287 | 3,851 |
| Reconciliation of Non-GAAP Loss: | Inventory related write-downs | 25 |  | 52 |  |
| Reconciliation of Non-GAAP Loss: | Acquisition-related costs | 1,143 |  | 2,870 |  |
| Reconciliation of Non-GAAP Loss: | Restructuring charges |  |  | 1,139 |  |
| Reconciliation of Non-GAAP Loss: | Adjusted EBITDA | -18,823 | -11,182 | -36,025 | -21,893 |

### Balance Sheet (December 31, — (In thousands) (in thousands))

| | June 30, – 2026 | December 31, – 2025 |
|---|---:|---:|
| Current assets | Cash and cash equivalents | 27,208 | 32,363 |
| Current assets | Investment securities, available-for-sale |  | 42,471 |
| Current assets | Restricted cash, current | 482 | 497 |
| Current assets | Accounts receivable, net of allowances | 915 | 47 |
| Current assets | Inventory | 3,660 | 745 |
| Current assets | Other current assets | 2,021 | 4,989 |
| Current assets | Total current assets | 34,286 | 81,112 |
| Current assets | Property and equipment, net | 15,787 | 4,280 |
| Current assets | Operating lease right-of-use assets | 17,655 | 14,075 |
| Current assets | Restricted cash, net of current portion | 1,184 | 1,204 |
| Current assets | Intangible assets, net | 13,684 | 32 |
| Current assets | Goodwill | 3,677 |  |
| Current assets | Other assets | 2,334 | 2,416 |
| Current assets | Total assets | 88,607 | 103,119 |
| Current liabilities | Accounts payable | 5,876 | 1,628 |
| Current liabilities | Accrued liabilities | 7,511 | 5,426 |
| Current liabilities | Deferred revenue | 253 |  |
| Current liabilities | Derivative liability | 7,050 |  |
| Current liabilities | Notes payable | 24,559 | 19,212 |
| Current liabilities | Operating lease liabilities, current | 5,119 | 3,481 |
| Current liabilities | Finance lease liabilities, current | 13 | 14 |
| Current liabilities | Other current liabilities | 43 | 388 |
| Current liabilities | Total current liabilities | 50,424 | 30,149 |
| Current liabilities | Warrant liability | 380 | 1,875 |
| Current liabilities | Operating lease liabilities, net of current portion | 15,743 | 14,034 |
| Current liabilities | Finance lease liabilities, net of current portion | 17 | 27 |
| Current liabilities | Other long-term liabilities | 1,424 | 1,486 |
| Current liabilities | Total liabilities | 67,988 | 47,571 |
| Shareholders’ equity | Common stock at par value | 23 | 20 |
| Shareholders’ equity | Additional paid-in capital | 1,039,358 | 1,012,121 |
| Shareholders’ equity | Accumulated other comprehensive income | 737 | 669 |
| Shareholders’ equity | Accumulated deficit | -1,019,499 | -957,262 |
| Shareholders’ equity | Total shareholders’ equity | 20,619 | 55,548 |
| Shareholders’ equity | Total liabilities and shareholders’ equity | 88,607 | 103,119 |

### Cash Flow (Six months ended June 30, — (In thousands) (in thousands))

| | Six months ended June 30, – 2026 | Six months ended June 30, – 2025 |
|---|---:|---:|
| Cash flows from operating activities | Net loss | -62,237 | -43,008 |
| Adjustments to reconcile net loss to net cash used in operations: | Depreciation and amortization | 5,344 | 2,952 |
| Adjustments to reconcile net loss to net cash used in operations: | Unrealized gain (loss) on derivative liability | 4,655 | -2,794 |
